Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peer recovery specialist-delivered, behavioral activation intervention to improve retention in methadone treatment: Results from an open-label, Type 1 hybrid effectiveness-implementation pilot trial.
Magidson JF, Kleinman MB, Bradley V, Anvari MS, Abidogun TM, Belcher AM, Greenblatt AD, Dean D, Hines A, Seitz-Brown CJ, Wagner M, Bennett M, Felton JW. Magidson JF, et al. Among authors: belcher am. Int J Drug Policy. 2022 Oct;108:103813. doi: 10.1016/j.drugpo.2022.103813. Epub 2022 Aug 3. Int J Drug Policy. 2022. PMID: 35932644 Free PMC article.
Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.
Cai NS, Quiroz C, Bonaventura J, Bonifazi A, Cole TO, Purks J, Billing AS, Massey E, Wagner M, Wish ED, Guitart X, Rea W, Lam S, Moreno E, Casadó-Anguera V, Greenblatt AD, Jacobson AE, Rice KC, Casadó V, Newman AH, Winkelman JW, Michaelides M, Weintraub E, Volkow ND, Belcher AM, Ferré S. Cai NS, et al. Among authors: belcher am. J Clin Invest. 2019 Mar 26;129(7):2730-2744. doi: 10.1172/JCI126912. J Clin Invest. 2019. PMID: 30913037 Free PMC article.
Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.
Belcher AM, Cole TO, Greenblatt AD, Hoag SW, Epstein DH, Wagner M, Billing AS, Massey E, Hamilton KR, Kozak ZK, Welsh CJ, Weintraub E, Wickwire EM, Wish ED, Kaptchuk TJ, Colloca L. Belcher AM, et al. BMJ Open. 2019 Jun 21;9(6):e026604. doi: 10.1136/bmjopen-2018-026604. BMJ Open. 2019. PMID: 31230007 Free PMC article.
Overdue for an Overhaul: How Opioid Treatment Programs Can Learn From COVID-19.
Greenblatt AD, Magidson JF, Belcher AM, Gandhi D, Weintraub E. Greenblatt AD, et al. Among authors: belcher am. Mayo Clin Proc. 2020 Oct;95(10):2076-2078. doi: 10.1016/j.mayocp.2020.08.011. Epub 2020 Aug 25. Mayo Clin Proc. 2020. PMID: 33012340 Free PMC article. No abstract available.
Race-based differences in drug use prior to onset of opioid use disorder.
Deutsch-Link S, Belcher AM, Massey E, Cole TO, Wagner MA, Billing AS, Greenblatt AD, Weintraub E, Wish ED. Deutsch-Link S, et al. Among authors: belcher am. J Ethn Subst Abuse. 2023 Jan-Mar;22(1):89-105. doi: 10.1080/15332640.2021.1879702. Epub 2021 Feb 7. J Ethn Subst Abuse. 2023. PMID: 33554763 Free PMC article.
159 results